NBY
Price:
$0.4458
Market Cap:
$2.18M
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was former...[Read more]
Industry
Biotechnology
IPO Date
2007-10-26
Stock Exchange
AMEX
Ticker
NBY
According to NovaBay Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.62. This represents a change of -50.16% compared to the average of 1.25 of the last 4 quarters.
The mean historical Current Ratio of NovaBay Pharmaceuticals, Inc. over the last ten years is 2.53. The current 0.62 Current Ratio has changed 2.37% with respect to the historical average. Over the past ten years (40 quarters), NBY's Current Ratio was at its highest in in the June 2021 quarter at 5.35. The Current Ratio was at its lowest in in the June 2024 quarter at 0.62.
Average
2.53
Median
2.16
Minimum
0.98
Maximum
5.03
Discovering the peaks and valleys of NovaBay Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 242.58%
Maximum Annual Current Ratio = 5.03
Minimum Annual Increase = -52.99%
Minimum Annual Current Ratio = 0.98
Year | Current Ratio | Change |
---|---|---|
2023 | 1.67 | -37.18% |
2022 | 2.66 | -30.43% |
2021 | 3.83 | -23.89% |
2020 | 5.03 | 204.76% |
2019 | 1.65 | -26.28% |
2018 | 2.24 | 23.86% |
2017 | 1.81 | -46.03% |
2016 | 3.35 | 242.58% |
2015 | 0.98 | -52.99% |
2014 | 2.08 | -49.04% |
The current Current Ratio of NovaBay Pharmaceuticals, Inc. (NBY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.72
5-year avg
2.97
10-year avg
2.53
NovaBay Pharmaceuticals, Inc.’s Current Ratio is less than Immix Biopharma, Inc. (7.00), greater than CNS Pharmaceuticals, Inc. (0.31), less than eFFECTOR Therapeutics, Inc. (1.03), greater than Navidea Biopharmaceuticals, Inc. (0.56), less than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than ZyVersa Therapeutics, Inc. (0.06), less than VectivBio Holding AG (9.14), less than AVROBIO, Inc. (26.17), less than Zura Bio Limited (12.57), less than Altamira Therapeutics Ltd. (1.38), less than Enveric Biosciences, Inc. (7.37), less than Palisade Bio, Inc. (4.31), less than Phio Pharmaceuticals Corp. (3.47),
Company | Current Ratio | Market cap |
---|---|---|
7.00 | $54.08M | |
0.31 | $4.60M | |
1.03 | $188.18K | |
0.56 | $100.08K | |
1.65 | $4.53M | |
0.06 | $2.70M | |
9.14 | $1.06B | |
26.17 | $5.24M | |
12.57 | $230.86M | |
1.38 | $2.04M | |
7.37 | $4.53M | |
4.31 | $4.25M | |
3.47 | $2.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBay Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NovaBay Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NovaBay Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for NovaBay Pharmaceuticals, Inc. (NBY)?
What is the highest Current Ratio for NovaBay Pharmaceuticals, Inc. (NBY)?
What is the 3-year average Current Ratio for NovaBay Pharmaceuticals, Inc. (NBY)?
What is the 5-year average Current Ratio for NovaBay Pharmaceuticals, Inc. (NBY)?
How does the current Current Ratio for NovaBay Pharmaceuticals, Inc. (NBY) compare to its historical average?